Market Takes Hit in...
Albany Molecular Research Inc. (AMRI: NASDAQ)
$2.90 0.05 | 1.75%
05/23/12 - 10:26 AM ET
24.41K / 106.20K
Vol / Avg. Vol:2.83 / 2.85
Open / Prev. Close:2.80 - 2.94
Today's Range:2.08 - 5.51
52 Wk Range:-2.73%
Performance YTD:TheStreet Rating:
Portfolios with AMRI
- Portfolio NameUser Type
- UserPART 7 JPMorgan 28th Annual...
- UserLast Day of the JPMorgan He...
- UserPART 7 JPMorgan 26th Annual...
- Userwafessler Portfolio 1
- UserSUPRATRADE SMALL CAP "...
- Userscorp Portfolio 1
- UserNew IDea
- Userctshagr Portfolio 1
- Useraaron81483 Portfolio 1
Latest AMRI Headlines from TheStreet
- Stocks Under $5: Hidden Value in Healthcare
09.01.11 | 05:09 am - Applespeed Fund Goes Bargain Hunting 10.30.10 | 06:10 am
- Albany Molecular Files Allegra Patent Lawsuits 09.15.09 | 10:09 am
- Movers Roundup: Urban Outfitters, Hot Topic 05.07.09 | 02:05 pm
- Albany Molecular Shares Fall On 1Q Profit, Outlook 05.07.09 | 11:05 am
- Health Winners & Losers: Onyx 08.06.08 | 05:08 pm
- Monday's Winners & Losers: Yahoo! 05.05.08 | 04:05 pm
- Monday's Health Winners & Losers 05.05.08 | 02:05 pm
- Monday's Health Winners & Losers 02.11.08 | 04:02 pm
- Cramer's 'Mad Money' Recap: Stimulus-Package Stock Plays 01.24.08 | 07:01 pm
Press Releases for AMRI
- AMRI Announces President For AMRI Europe - PR Newswire 05.22.12 | 08:05 am
- William S. Marth Appointed To AMRI's Board Of Directors - PR Newswire 05.07.12 | 08:05 am
- AMRI To Announce First Quarter Results - PR Newswire 05.02.12 | 08:05 am
- AMRI Announces Development And Manufacturing Deal With Biota Holdings Limited - PR Newswire 04.17.12 | 08:04 am
- AMRI Signs Exclusive Option To License Its Tubulin Inhibitor Program For Cancer - PR Newswire 04.03.12 | 08:04 am
- AMRI CFO To Present At 11th Annual Needham Healthcare Conference - PR Newswire 03.28.12 | 08:03 am
- AMRI Hires Senior Manager To Oversee Facilities At Burlington Aseptic Fill Operations - PR Newswire 03.27.12 | 08:03 am
- AMRI Expands Quality Control Leadership To Support Future Growth - PR Newswire 02.29.12 | 08:02 am
- AMRI CFO To Present At UBS 22nd Annual Global Healthcare Services Conference - PR Newswire 02.01.12 | 08:02 am
- AMRI To Announce Fourth Quarter Results - PR Newswire 01.31.12 | 08:01 am
Partner Headlines for AMRI
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 11.14.11 | 09:11 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 11.10.11 | 09:11 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.10.11 | 09:08 am
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 11.12.10 | 09:11 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 10.05.10 | 09:10 am
- UPDATE 1-Albany Molecular says facility gets warning letter - Reuters 08.20.10 | 06:08 pm
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 08.06.10 | 09:08 am
- UPDATE 1-Albany Molecular buys pre-filled syringe co for $27mln - Reuters 06.15.10 | 08:06 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 05.10.10 | 09:05 am





